A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | AA | AB | AC | AD | AE | AF | AG | AH | AI | AJ | AK | AL | AM | AN | AO | AP | AQ | AR | AS | AT | AU | AV | AW | AX | AY | AZ | BA | BB | BC | BD | BE | BF | BG | BH | BI | BJ | BK | BL | BM | BN | BO | BP | BQ | BR | BS | BT | BU | BV | BW | BX | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Case ID | Location | Why was the case tested for COVID-19? | Diagnosis | Vaccination status | Clinical features | Suspected but not confirmed | Age | Sex at birth | MS phenotype | Non-MS diagnosis | Disease Severity | DMT information | Lab Tests | Pregnancy and comorbidities | Resolution if appropriate - choose best option | Treatment information | Outcome after receiving treatment for Sotrovimb or other antiviral treatments | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2 | submitted to MSIF/MSDA | Case number | Is this person enrolled in the MSBase Registry? | If known, please add the MSBase ID number (this is to track duplicated data entry) | Report Date (DD-MM-YYYY) | Country reporting (AUS or NZ) | Dr reporting (initials). Please note that data entered will become hidden after entering | City | Date of diagnosis | Confirmed COVID-19 test | Type of COVID-19 test | Has the patient received a COVID vaccine at the time of the diagnosis? | What COVID vacccine did the patient receive? | How many doses has the patient received of the vaccine? | Does the patient have symptoms? | If initially asymptomatic, what date the the patient develop symptoms? | Fever (in 99 %, subjective or confirmed) | Fatigue (seen in 70%) | Cough (59%) | Sore throat | Anosmia | Pain (joint, bone, muscle) | Pneumonia | Other | Susepcted COVID-19: known contact/travel history/point of exposure/unwell with at least 2 of the core clinical features present (J-N) | Suspected COVID-19: any patient with severe LOWER respiratory tract illness without an alternative aetiology even if no clear exposure. | Please note that data entered will become hidden after entering | M/F | CIS/RR/ SP/PP | NMO/NMOSD/ MG/ CIDP/AIE/Sarcoid | Most recent EDSS before onset of COVID19 | Date of EDSS assessment | Is the patient currently on DMT? | DMT- current | Last exposure to DMT (DATE) | Last Lymphocyte count before COVID19 | Last B cell count or CD19/CD20 count before COVID19 | Date of last recorded lymphocyte or Bcell/CD19/CD20 count | Pregnancy | Pregnancy Trimester | Does the patient have other comorbidities? | Smoking history | Weight (kg) | Height (cm) | Calculated BMI | Estimated Body Mass Index (if weight/height not known) | Cardiovascular incl. Hypertension | Diabetes | Chronic lung disease | Renal disease | Liver disease | Malignancy | Other comorbidities of note | If initially asymptomatic, what date the the patient develop symptoms? | Was the patient admitted to hospital | Date of admission to hospital | Date of discharge from hospital | Was the patient admitted to an ICU | Did the patient require ventilation in ICU? | Type of ventilation needed | Duration of stay in ICU (days) | Patient Status (outcome) | Patient outcome other | Date of outcome reported | Was the DMT continued during the infection? | Treatment given in response to the infection e.g IVIG, corticosteroids, antibiotics, anti-virals, anti-malarials | ||||||||||
3 | Case_ID | MSBase_enrolled | MSBaseID | covid19_date_reporting | covid19_country | Covid19_city | covid19_whytested | covid19_date_lab_test | covid19_confirmed_case | type_COVID19_test | COVID_Vaccine_received | COVID_Vaccine_type | Vaccine_doses | covid19_has_symptoms | covid19_date_suspected_onset | covid19_sympt_fever | covid19_sympt_fatigue | covid19_sympt_dry_cough | covid19_sympt_sore_throat | covid19_sympt_loss_smell_taste | covid19_sympt_pain | covid19_sympt_pneumonia | covid19_suspected_case | covid19_suspected_case_pneumonia | sex | ms_type | other_NIC_type | edss_value | edss_date_diagnosis | current_dmt | type_dmt | dmt_exposure_date | last_lympho_cell | last_b_cell | date_lympho_bcells | pregnancy | pregnancy_trimester | has_comorbidities | smoker | weight | Height | BMI_calculated | BMI_estimated_category | com_cardiovascular_disease | com_diabetes | com_lung_disease | com_chronic_kidney_disease | com_chronic_liver_disease | com_malignancy | com_other | covid19_date_suspected_onset | covid19_admission_hospital | covid19_admission_hospital_date | covid19_admission_hospital_release | covid19_icu_stay | covid19_ventilation | covid19_ventilation_type | covid19_icu_total_duration | covid19_outcome | covid19_outcome_other | covid19_outcome_date | dmt_ceased_dueto_covid19 | covid19_extratreatment_given | |||||||||||||
4 | 10/8/2020 | #0001 | 16/03/2020 | AUS | Perth | Repatriation | 12/03/2020 | Y | PCR | Y | Y | Y | Y | unknown | N | N | not applicable | F | RR | Ocrevus | 07/12/2019 | 1.5 | 0 | 29/11/2019 | N | N | #DIV/0! | N | N | N | N | N | No | N | Recovered | 26/03/2020 | None | |||||||||||||||||||||||||||||||||||||||
5 | 10/8/2020 | #0002 | 17/03/2020 | AUS | sydney | Case_contact | 17/03/2020 | Y | PCR | Y | Y | Y | unknown | unknown | Y | N | not applicable | F | RR | Gilenya | current | 0.5 | N | N | #DIV/0! | N | Recovered | |||||||||||||||||||||||||||||||||||||||||||||||||
6 | N/A | #0003 | N | AUS | Brisbane | Y | Y | unknown | not applicable | not MS | MG | MMF | current | N | #DIV/0! | N | Recovered | IVIG | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
7 | 10/8/2020 | #0004 | N | 22/03/2020 | NZ | Dunedin | Repatriation | 19/03/2020 | Y | PCR | Y | Y | unknown | Y | Y | unknown | not applicable | F | RR | 1 | 01/12/2019 | Fingolimod | 19/03/2020 | 0.4 | 19/03/2020 | N | Y | #DIV/0! | Asthma | N | N | N | Recovered | 02/04/2020 | unknown | None | ||||||||||||||||||||||||||||||||||||||||
8 | 10/8/2020 | #0005 | 31/03/2020 | AUS | Sydney | Repatriation | 24/03/2020 | Y | PCR | Y | Y | Y | Y | N | N | not applicable | F | RR | Ocrevus | 12/2019 | 1.3 | 20/11/2019 | N | Y | #DIV/0! | Y | Cryptococcal osteomyelitis | N | Recovered | 31/03/2020 | None | |||||||||||||||||||||||||||||||||||||||||||||
9 | 10/8/2020 | #0006 | N | 21/4/2020 | AUS | Melbourne | Seeking_Health_care | 30/3/2020 | Y | PCR | Y | Y | Y | Y | Y | unknown | unknown | N | not applicable | F | RR | 5.5 | 25/05/2019 | Y | Fingolimod | current | 0.6 | 23/4/2019 | N | Y | #DIV/0! | Y | N | N | N | N | No | Y | 31/3/2020 | 07/04/2020 | N | Recovered | 14/04/2020 | continued | None | |||||||||||||||||||||||||||||||
10 | 10/8/2020 | #0007 | Y | 14/5/2020 | AUS | Melbourne | Repatriation | 12/5/2020 | Y | PCR | Y | Y | Y | Y | Y | Y | Y | N | not applicable | not applicable | F | RR | 2 | 24/1/2019 | Y | Ocrevus | 02/2020 | 1.4 | 0 | 02/02/2020 | N | N | #DIV/0! | N | N | Recovered | 15/05/2020 | continued | ||||||||||||||||||||||||||||||||||||||
11 | 10/8/2020 | #0008 | N | 30/7/20 | AUS | Geelong | Seeking_Health_care | 19/7/20 | Y | PCR | Y | Y | Y | Y | Y | Y | Y | Y | N | not applicable | not applicable | F | RR | Y | Fingolimod | 30/7/20 | 0.3 | N | Y | Never smoked | 80 | 163 | 30.1102789 | Overweight (BMI 25-30) | Y | N | N | N | N | No | N | 14/7/2020 | N | Recovered | 04/08/2020 | continued | recent branch retinal vein occlusion commenced asirin | |||||||||||||||||||||||||||||
12 | 10/8/2020 | #0009 | N | 30/7/2020 | AUS | Melbourne | Case_contact | 13/7/2020 | Y | PCR | N | N | N | N | N | N | N | N | N | not applicable | not applicable | M | RR | 0 | 11/2/2020 | Y | Fingolimod | 30/7/20 | 0.6 | N | Y | Never smoked | 107 | 174 | 35.34152464 | Obese (BMI 30-40) | N | N | N | N | N | No | N | N | N | Recovered | 30/7/2020 | continued | ||||||||||||||||||||||||||||
13 | in MSBase study | #0010 | Y | AU-025-0036 | 07/09/2020 | AUS | Melbourne | Case_contact | 01/09/2020 | Y | PCR | Y | Y | Y | Y | Y | N | Y | N | not applicable | not applicable | F | RR | 6.5 | 17/07/2019 | Y | Ocrevus | 28/05/2020 | 1.2 | 28/05/2020 | N | Y | Never smoked | 72 | 152 | 31.1634349 | Obese (BMI 30-40) | Y | N | N | N | N | No | N | N | N | N | Recovered | 05-09-2020 | continued | None | |||||||||||||||||||||||||
14 | in MSBase study | #0011 | Y | AU-009-0614 | 07/09/2020 | AUS | Melbourne | Surveillance | 27/05/2020 | Y | PCR | Y | N | Y | Y | Y | N | N | N | not applicable | not applicable | F | RR | 2 | 18/12/2019 | Y | Ocrevus | 14/04/2020 | 0.21 | 18/12/2019 | N | Y | Never smoked | #DIV/0! | N | N | N | N | N | No | Anterior pituitary adenoma syndrome | N | N | N | Recovered | 05/06/2020 | continued | None | ||||||||||||||||||||||||||||
15 | in MSBase study | #0012 | Y | AU-025-0005 | 07/09/2020 | AUS | Melbourne AH | Surveillance | 02/09/2020 | Y | PCR | Y | Y | N | Y | N | N | N | N | not applicable | not applicable | M | SP | 7 | 05/02/2020 | Y | Ocrevus | 21/04/2020 | 1.07 | 21/04/2020 | N | Y | Ex-smoker | 154 | 0 | N | N | N | N | N | N | N | Y | 09/09/2020 | 16/09/2020 | N | N | Recovered | 15/09/2020 | continued | Ceftriaxone, azithromycin, remdesivir, dexamethasone | |||||||||||||||||||||||||
16 | 17/11/2020 | #0013 | N | 14/09/2020 | Aus | Melbourne | Case_contact | 02/08/2020 | Y | PCR | Y | 01/08/2020 | Y | N | Y | N | N | N | N | not applicable | not applicable | M | RR | 1 | 24/06/2020 | Y | Ocrevus | 07/07/2020 | 03/09/2020 | N | N | Y | Never smoked | 84 | 180 | 25.92592593 | Y | N | N | N | N | N | Hypothyroidism | 01/08/2020 | N | Recovered | 16/09/2020 | continued | None | |||||||||||||||||||||||||||
17 | 17/11/2020 | #0014 | N | 14/10/2020 | AUS | Melbourne | Seeking_Health_care | 27/07/2020 | Y | PCR | Y | N | N | Y | Y | Y | N | N | not applicable | not applicable | M | RR | 1.5 | 01/02/2020 | Y | Gilenya | ongoing | 0.2 | N | N | Current Smoker | 85 | 180 | 26.2345679 | N | N | N | N | N | No | N | Recovered | 20/8/2020 | continued | antibiotics | |||||||||||||||||||||||||||||||
18 | 17/11/2020 | #0015 | Y | AU-009-1062 | 14/10/2020 | AUS | Melbourne | Case_contact | 23/8/2020 | Y | PCR | Y | N | Y | N | N | N | N | N | not applicable | not applicable | M | SP | 6.5 | 01/02/2020 | Y | Aubagio | ongoing | 1 | 04/07/2020 | N | Y | Current Smoker | #DIV/0! | Y | N | Y | N | N | No | Y | 09/07/2020 | 23/08/2020 | N | N | Recovered | 23/9/2020 | discontinued or dose delayed whilst unwell | nil | |||||||||||||||||||||||||||
19 | #0016 | N | 3/8/2020 | AUS | Melbourne | Case_contact | 03/08/2020 | Y | PCR | Y | N | N | N | Y | Y | N | N | not applicable | not applicable | F | RR | 4 | Y | Tysabri | 01/07/2020 | N | Y | Never smoked | 96 | 155 | 39.95837669 | N | N | N | N | N | N | Neurofibromatosis, Hypothyroidism | N | Recovered | discontinued or dose delayed whilst unwell | |||||||||||||||||||||||||||||||||||
20 | #0017 | Y | AU-025-1747 | 23/08/2020 | AUS | Melbourne | Case_contact | 23/08/2020 | Y | PCR | Y | Y | Y | Y | Y | N | N | Y | F | SP | 9 | 20/10/2017 | Y | Tecfidera | ongoing | 1.1 | N | N | #DIV/0! | N | N | N | N | N | No | N | Recovered | 10/10/2020 | continued | steroids | ||||||||||||||||||||||||||||||||||||
21 | #0018 | N | 09/06/2021 | AUS | Sydney | Seeking_Health_care | 02/01/2021 | Y | PCR | Y | Y | Y | N | N | Y | N | N | not applicable | not applicable | M | RR | 1 | 11/12/2020 | Y | Tecfidera | ongoing | N | Y | Never smoked | 110 | 175 | 35.91836735 | N | N | N | N | Y | No | Fatty liver disease | N | N | Recovered | Ongoing anosmia | 06.09.2021 | discontinued or dose delayed whilst unwell | Nil | ||||||||||||||||||||||||||||||
22 | #0019 | N | 18/9/2021 | AUS | Melbourne | Case Contact | 13/09/2021 | Y | PCR | Y | Y | Y | Y | Y | N | Y | N | N | not applicable | not applicable | F | PP | 3.5 | 05/06/2021 | Y | Ocrelizumab | ongoing | 1.6 | N | N | Never smoked | 55 | 160 | 21.484375 | N | N | N | N | N | No | N | N | NA | N | N | NA | Recovered | 11/10/2021 | not applicable | Nil | ||||||||||||||||||||||||||
23 | #0020 | Y | AU-026-1587 | 12/10/2021 | AUS | Melbourne | Case_contact | 06/10/2021 | Y | PCR | Y | 4/10/2021 | Y | Y | Y | N | unknown | unknown | N | not applicable | F | RR | 3.5 | 02/11/2018 | Y | Gilenya | ongoing | 0.6 | 26/03/2021 | N | N | Never smoked | 55 | 155 | 22.89281998 | N | N | N | N | N | No | N | continued | |||||||||||||||||||||||||||||||||
24 | #0021 | N | 12/10/2021 | AUS | Melbourne | Case_contact | 27/09/2021 | Y | PCR | Y | 23/09/2021 | Y | Y | Y | Y | unknown | Y | N | not applicable | F | RR | 0 | 02/03/2020 | Y | Gilenya | ongoing | 0.7 | 07/07/2021 | N | N | Never smoked | 56 | 165 | 20.56932966 | N | N | N | N | N | No | N | permanently ceased | ||||||||||||||||||||||||||||||||||
25 | #0022 | Y | AU-025-0014 | 08/10/2021 | AUS | Melbourne | Case_contact | 08/10/2021 | Y | PCR | N | Y | 01/10/2021 | N | Y | Y | N | N | Y | N | not applicable | M | PP | 2 | 07/09/2011 | Y | Ocrelizumab | 19/04/2021 | 1.79 | 19/04/2021 | N | N | Current Smoker | 74 | 175 | 24.16326531 | N | N | N | N | N | No | N | |||||||||||||||||||||||||||||||||
26 | #0023 | Y | TBA - RMH t/fer | 18/10/2021 | AUS | Melbourne | Seeking_Health_care | 16/10/2021 | Y | PCR | Y | Pfizer | 2 | Y | 14/10/2021 | Y | Y | Y | N | Y | Y | N | not applicable | not applicable | F | RR | unknown | unknown | N | n/a | n/a | 0.86 | 20/10/2021 | N | Y | Never smoked | 79 | 157 | 32.04998174 | Y | N | Y | N | N | No | N | Recovered | 30/10/2021 | not applicable | |||||||||||||||||||||||||||
27 | #0024 | Y | AU-016-0020 | 01/11/2021 | AUS | SYDNEY | Seeking_Health_care | 28/08/2021 | Y | PCR | N | N | 28/08/2021 | Y | Y | N | N | N | N | N | M | SP | 8.5 | Aug 2021 | N | 03/10/2019 | 1 | N | Y | Ex-smoker | 109 | 188 | 30.83974649 | N | N | N | N | N | No | 28/08/2021 | Y | NOSOCOMIAL | 15/09/2021 | N | Recovered | not applicable | PATIENT WAS ADMITTED IN THE HOSPITAL FOR Pseudomonas UTI in context of long-term SPC. CLOSE CONTACT IN THE HOSPITAL AND ACQUIRED COVID. TREATED WITH DEXAMETHASONE AND SOTROVIMAB, WAS ALREADY ON ANTIBIOTIC FOR UTI. | |||||||||||||||||||||||||||||
28 | #0025 | N | 01/11/2021 | AUS | SYDNEY | Case_contact | 10/09/2021 | Y | PCR | Y | Pfizer | 1 | Y | 10/09/2021 | N | Y | N | Y | N | Y | N | F | RR | 1 | 23/07/2021 | Y | CLADRIBINE | 22/07/2021 | 0.6 | 0.24 | 07/06/2021 | N | Y | 98 | #DIV/0! | Y | N | N | N | N | No | N | Recovered | discontinued or dose delayed whilst unwell | TREATED WITH SOTROVIMAV ON DAY 4 FROM THE ONSET OF SYMPTOMS, had Pfizer vaccine first dose on the same day of diagnosis | |||||||||||||||||||||||||||||||
29 | #0026 | Y | AU-016-0399 | 01/11/2021 | AUS | SYDNEY | Case_contact | 15/09/2021 | Y | PCR | N | Y | 12/09/2021 | Y | Y | Y | N | Y | unknown | N | F | RR | 1 | 01/03/2021 | Y | Ocrelizumab | 24/05/2021 | 1.1 | 0.01 | 06/05/2021 | N | Y | 88 | 160 | 34.375 | N | N | N | N | N | No | asthma | 12/09/2021 | N | Recovered | TREATED WITH SOTROVIMAV ON DAY 4 FROM THE ONSET OF SYMPTOMS | ||||||||||||||||||||||||||||||
30 | #0027 | Y | AU-016-0507 | 01/11/2021 | AUS | SYDNEY | Case_contact | 15/09/2021 | Y | PCR | N | Y | N | Y | Y | Y | Y | Y | unknown | F | RR | 0 | 02/06/2021 | Y | CLADRIBINE | 04/06/2020 | 1.1 | 0.03 | 02/06/2021 | N | N | Never smoked | 70 | #DIV/0! | N | N | N | N | N | No | N | Recovered | 15/10/2021 | not applicable | symptoms managment only at home such as paracetamol for body pain | |||||||||||||||||||||||||||||||
31 | #0028 | Y | AU-016-0199 | 01/11/2021 | AUS | SYDNEY | Case_contact | 14/09/2021 | Y | PCR | Y | Y | 14/09/2021 | Y | Y | Y | Y | N | Y | Y | F | RR | 3.5 | 27/05/2021 | Y | CLADRIBINE | 26/07/2020 | 1.24 | 0.32 | 06/08/2021 | N | N | Never smoked | 65 | 168 | 23.03004535 | N | N | N | N | N | No | 14/09/2021 | Y | 19/09/2021 | 25/09/2021 | N | Recovered | discontinued or dose delayed whilst unwell | 35 year old female admitted to Liverpool Hospital from 19/9/21 to 25/09/21. She was admitted under the care of Dr Johnson and was investigated and managed as an inpatient. This patient initially presented with lethargy and light-headedness, secondary to COVID 19 pneumonitis. She was found to be neutropaenic which was stable through admission, treated with IV tazocin. She remained stable, did not require oxygen and was fit for discharge. | ||||||||||||||||||||||||||
32 | #0029 | Y | AU-016-0172 | 01/11/2021 | AUS | SYDNEY | Case_contact | 10/10/2021 | Y | PCR | Y | Pfizer | 1 | Y | Y | Y | Y | N | N | Y | unknown | F | SP | 4 | 26/06/2020 | Y | CLADRIBINE | 30/11/2020 | 0.67 | 0.19 | 15/10/2020 | N | Y | Current Smoker | 97 | 160 | 37.890625 | Y | N | N | N | N | No | N | NOTrecovered | not fully recovered. She continues to have a congested chest and cough. She sounds like she is losing her voice. Very low energy levels as well. | 02/11/2021 | not applicable | TREATED WITH SOTROVIMAV ON DAY 4 FROM THE ONSET OF SYMPTOMS | |||||||||||||||||||||||||||
33 | #0030 | Y | AU-016-0552 | 02/11/2021 | AUS | SYDNEY | Case_contact | 26/10/2021 | Y | PCR | N | AstraZeneca | 2 | Y | 25/10/2021 | Y | Y | Y | Y | Y | Y | unknown | F | RR | 2.5 | 24/07/2020 | Y | CLADRIBINE | 21/11/2020 | N | N | Current Smoker | 74 | 163 | 27.85200798 | N | N | N | N | N | No | N | NOTrecovered | patient still has mild cough, fatigue, body pain and loss of taste | 02/11/2021 | not applicable | TREATED WITH SOTROVIMAV ON DAY 2 FROM THE ONSET OF SYMPTOMS, | |||||||||||||||||||||||||||||
34 | #0031 | N | 03/11/2021 | AUS | Melbourne | Case_contact | 28/10/2021 | Y | PCR | Y | Pfizer | 2 | Y | 25/10/2021 | Y | N | Y | Y | Y | Y | N | F | RR | 1 | 29/10/2019 | Y | Betaferon | Ongoing | N | N | Never smoked | 90 | 172 | 30.42184965 | N | N | N | N | N | No | ||||||||||||||||||||||||||||||||||||
35 | #0032 | Y | AU-026-0769 | 03/11/2021 | AUS | Melbourne | Case_contact | 25/10/2021 | Y | PCR | Y | Pfizer | 2 | Y | 26/10/2021 | N | Y | Y | N | Y | N | N | F | RR | 1 | 23/02/2021 | Y | Lemtrada | 09/2018 | 2.3 | N | N | Never smoked | 70 | 163 | 26.34649403 | N | N | N | N | N | No | ||||||||||||||||||||||||||||||||||
36 | #0033 | Y | AU-026-1323 | 03/11/2021 | AUS | Melbourne | Case_contact | #DIV/0! | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
37 | #0034 | N | 03/11/2021 | AUS | Melbourne | Case_contact | #DIV/0! | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
38 | #0035 | N | 4/11/21 | AUS | Melbourne | Case_contact | 13/10/21 | Y | PCR | N | Y | Y | Y | Y | Y | Y | Y | N | not applicable | not applicable | F | RR | Y | Ocrevus | 20/8/21 | 0.4 | 1/9/21 | N | Y | Current Smoker | 102 | 164 | 37.92385485 | N | N | N | N | N | No | CIDP Hypothyroidism | Y | 14/10/21 | 14/10/21 | N | Recovered | not fully recovered 4/11/21 | not applicable | IVIG was given for CIDP 10/10/21. Sotrivamab given 14/10/21. Panadol Nurofen Endone | ||||||||||||||||||||||||||||
39 | #0036 | N | 4/11/21 | AUS | Melbourne | Case_contact | 20/10/21 | Y | PCR | Y | AstraZeneca | 2 | Y | Y | Y | Y | Y | Y | Y | N | not applicable | not applicable | F | RR | Y | Ocrevus | 17/9/21 | 2.74 | 0.02 | 11/9/21 | N | N | Never smoked | 100 | 153 | 42.7186125 | N | N | N | N | N | No | Lupus | N | Recovered | Not fully recovered ongoing cough and fatigue | not applicable | Keflex for secondary sinus infection , panadol nurofen | ||||||||||||||||||||||||||||
40 | #0037 | N | 5/11/21 | AUS | Melbourne | Seeking_Health_care | 8/10/21 | Y | PCR | N | Y | N | Y | Y | Y | Y | Y | N | not applicable | not applicable | F | RR | Y | Tysabri | 12/9/21 | N | N | Never smoked | 75 | 158 | 30.0432623 | N | N | N | N | N | No | asthma | N | Recovered | discontinued or dose delayed whilst unwell | |||||||||||||||||||||||||||||||||||
41 | #0038 | Y | AU-009-0271 | 10/11/21 | AUS | Melbourne | Case_contact | 09/11/21 | Y | PCR | Y | Pfizer | 2 | Y | Y | N | N | N | N | N | N | not applicable | not applicable | F | RR | 0 | 321/03/2021 | Y | Ocrevus | 01/06/21 | N | N | #VALUE! | |||||||||||||||||||||||||||||||||||||||||||
42 | #0039 | N | 26/11/21 | AUS | Geelong | Case_contact | 28/11/21 | y | PCR | Y | Pfizer | 3 | Y | Y | Y | Y | Y | Y | Y | N | not applicable | not applicable | M | RR | 0 | 18/11/2021 | Y | Ocrevus | 03/09/2021 | 1.5 | N | Never smoked | #DIV/0! | N | N | N | N | N | No | N | ||||||||||||||||||||||||||||||||||||
43 | #0040 | Y | AU-025-1656 | 30/11/2021 | AUS | Melbourne | Seeking_Health_care | 25/11/21 | Y | PCR | Y | Pfizer | 2 | Y | 25/11/2021 | #DIV/0! | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
44 | #0041 | N | 6/12/21 | AUS | Geelong | Case_contact | 30/11/21 | Y | PCR | Y | Pfizer | 2 | Y | 29/11/21 | Y | Y | Y | Y | N | Y | N | not applicable | not applicable | M | RR | Y | Lemtrada Year 4 | 2018 | 1.4 | N | Current Smoker | 94 | 178 | 29.66797122 | N | N | N | N | N | No | 29/11/21 | N | N | Recovered | 6/12/21 | not applicable | Sotrivimab 2/12/21 | Had IV steroids in September weeks after 2nd Pfizer | ||||||||||||||||||||||||||||
45 | #0042 | N | AU-025-1864 | 11/1/22 | AUS | Melbourne | Seeking_Health_care | 22/11/21 | Y | PCR | Y | Moderna | 1 | Y | Y | Y | Y | Y | N | N | N | not applicable | not applicable | M | RR | 4.5 | 31/03/2021 | Y | Ocrevus | 06/09/21 | 0.8 | 04/11/21 | N | N | Never smoked | #DIV/0! | N | N | N | N | N | No | N | Recovered | 6/12/21 | not applicable | Sotrovimab given | |||||||||||||||||||||||||||||
46 | #0043 | N | 14/1/22 | AUS | Geelong | Case_contact | 4/1/22 | Y | PCR | Y | AstraZeneca | 2 | Y | 29/12/21 | Y | Y | Y | Y | N | N | N | F | RR | 1 | 6/7/21 | Y | Tysabri | 6/12/21 | 4.9 | 16/8/21 | N | N | Never smoked | 72 | 173 | 24.05693475 | N | N | N | N | N | No | 29/12/21 | N | N | Recovered | 14/1/22 | discontinued or dose delayed whilst unwell | Nil | |||||||||||||||||||||||||||
47 | #0044 | N | 14/1/22 | AUS | Geelong | Case_contact | 30/12/21 | Y | PCR | Y | Pfizer | 3 | Y | 30/1/21 | Y | Y | Y | N | N | Y | N | F | RR | 0 | 8/7/21 | Y | Tysabri | 20/12/21 | 3.1 | 25/10/21 | N | Y | Never smoked | 85 | 173 | 28.40054796 | N | N | N | N | N | No | Chronic Asthma | 30/12/21 | N | N | Recovered | slight residual cough | 14/1/22 | continued | Nil | |||||||||||||||||||||||||
48 | #0045 | N | 14/1/22 | AUS | Geelong | Seeking_Health_care | 12/1/22 | Y | PCR | Y | Pfizer | 3 | Y | 4/1/22 | Y | Y | Y | Y | N | Y | N | F | RR | 0 | 3/12/21 | Y | Ocrevus | 26/8/21 | 2.5 | 14/8/21 | N | N | Never smoked | 60 | 178 | 18.9370029 | N | N | N | N | N | No | 4/1/22 | N | Recovered | residual cough, runny nose | 14/1/22 | not applicable | Sotrovimab given 7/1/22 | 2 Pfizer, 1 x Moderna | ||||||||||||||||||||||||||
49 | #0046 | N | 14/1/22 | AUS | Geelong | Point_of_exposure_detection | 4/1/22 | Y | PCR | Y | Pfizer | 2 | Y | 2/1/22 | N | Y | Y | Y | N | Y | N | F | RR | 1.5 | 23/12/21 | Y | Tysabri | 13/12/21 | 4.9 | 23/8/21 | N | N | Never smoked | 73 | 176 | 23.56663223 | N | N | N | N | N | No | 2/1/22 | N | N | Recovered | residual chest cough | 14/1/22 | discontinued or dose delayed whilst unwell | Tysabri delayed 5 days. GP prescribed antibiotics post C-19 for ? chest infection. | ||||||||||||||||||||||||||
50 | #0047 | N | 14/1/22 | AUS | Geelong | Case_contact | 7/1/22 | Y | Other | Y | Pfizer | 3 | Y | 6/1/22 | Y | Y | Y | Y | Y | N | N | F | RR | 0 | 7/10/21 | Y | Ocrevus | 10/09/21 | 1.3 | 24/8/21 | N | N | Never smoked | 120 | 155 | #REF! | Y | N | N | N | N | No | 6/1/22 | N | N | Recovered | loss of taste and smell persists14/1;222 | continued | Sotrovimab 9/1/22 | 2 Pfizer 1 x Moderna | ||||||||||||||||||||||||||
51 | #0048 | N | 14/1/22 | AUS | Geelong | Case_contact | 4/1/22 | Y | Other | Y | Pfizer | 2 | Y | 3/1/22 | N | Y | Y | Y | N | N | N | F | RR | Y | Ocrevus | 6/12/21 | N | N | Never smoked | 71 | 175 | 29.55254943 | N | N | N | N | N | No | 4/1/22 | N | Recovered | 14/1/22 | continued | Nil | ||||||||||||||||||||||||||||||||
52 | #0049 | N | 14/1/22 | AUS | Geelong | Seeking_Health_care | NO | N | Other | Y | Pfizer | 2 | Y | 6/1/22 | Y | Y | N | Y | N | Y | N | not applicable | Y | M | RR | 0 | 18/11/21 | Y | Ocrevus | 15/11/21 | 5.5 | 11/11/21 | N | N | Never smoked | 81 | 183 | 24.18704649 | N | N | N | N | N | No | 6/1/22 | N | Recovered | 14/1/22 | continued | Nil | ||||||||||||||||||||||||||
53 | #0050 | N | AU-025-2214 | 19/1/22 | AUS | Melbourne | Seeking_Health_care | 09/01/21 | Y | PCR | Y | Pfizer | 3 | Y | 06/01/22 | Y | Y | Y | Y | N | N | N | N | N | M | RR | Y | Ocrevus | 13/09/21 | 1.72 | 19/11/21 | N | N | Ex-smoker | #DIV/0! | N | N | N | N | N | No | N | Recovered | persistant fatigue, sweating and cough | 19/01/22 | not applicable | nil | |||||||||||||||||||||||||||||
54 | #0051 | Y | AU-025-2216 | 19/01/22 | AUS | Melbourne | Seeking_Health_care | 26/12/21 | Y | PCR | Y | Pfizer | 3 | Y | 26/12/21 | Y | N | Y | N | N | N | N | not applicable | not applicable | M | RR | 1 | 28/04/21 | Y | Ocrevus | 09/12/21 | 1.33 | 10/06/21 | N | N | Ex-smoker | #DIV/0! | N | N | N | N | N | No | N | N | Recovered | 05/01/22 | not applicable | nil | |||||||||||||||||||||||||||
55 | #0052 | N | 20/01/22 | AUS | Gold Coast | Seeking_Health_care | 19/01/22 | Y | PCR | Y | not applicable | not applicable | F | RR | Y | Alemtuzumab | #DIV/0! | Y | not applicable | Sotrovimab | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
56 | #0053 | N | 27/01/2022 | AUS | Gold Coast | Seeking_Health_care | 12/01/2022 | Y | PCR | Y | Pfizer | 3 | Y | N | Y | N | N | N | N | N | not applicable | not applicable | F | RR | 1 | 25/01/22 | Y | Natalizumab | 24/12/21 | 3.36 | 29/07/21 | N | N | #DIV/0! | N | N | N | N | N | No | N | N | Recovered | 25/01/22 | discontinued or dose delayed whilst unwell | nil | ||||||||||||||||||||||||||||||
57 | #0054 | Y | AU-025-2210 | 05/02/22 | AUS | Melbourne | Seeking_Health_care | 10/01/22 | Y | PCR | Y | Pfizer | 2 | Y | 05/01/22 | N | Y | Y | Y | N | N | N | not applicable | not applicable | F | RR | 1 | 09/06/21 | Y | Ocrevus | 14/10/21 | 1.1 | 14/10/21 | N | N | Never smoked | #DIV/0! | N | N | N | N | N | No | N | Unknown | not applicable | ||||||||||||||||||||||||||||||
58 | #0055 | Y | AU-009-0974 | 05/02/22 | AUS | Melbourne | Seeking_Health_care | 05/01/22 | Y | PCR | Y | AstraZeneca | 2 | Y | 04/01/22 | N | N | N | Y | N | N | N | not applicable | not applicable | M | RR | 6.5 | 22/09/21 | Y | Siponimod | 05/01/22 | 0.4 | 17/03/21 | N | N | #DIV/0! | N | N | N | N | N | No | 04/01/21 | N | Recovered | 12/01/22 | continued | Sotrovimab 8/1/22 | ||||||||||||||||||||||||||||
59 | #0056 | Y | AU-025-0236 | 05/02/22 | AUS | Melbourne | Seeking_Health_care | 20/01/22 | Y | PCR | Y | unknown | 3 | Y | 20/01/22 | Y | Y | Y | Y | N | N | N | not applicable | not applicable | M | RR | 0 | 05/05/21 | Y | Ocrevus | 27/10/21 | 0.56 | 27/10/21 | N | N | #DIV/0! | N | N | N | N | N | No | 21/01/22 | N | not applicable | Sotrovimab 24/01/22 | ||||||||||||||||||||||||||||||
60 | #0057 | Y | AU-025-2246 | 05/02/22 | AUS | Melbourne | Seeking_Health_care | 01/12/21 | Y | PCR | Y | N | Y | Y | N | N | N | not applicable | not applicable | M | RR | 2 | 30/11/21 | Y | Ocrevus | 06/07/21 | 2.09 | 20/04/21 | N | Y | #DIV/0! | Y | Y | N | N | N | No | N | Recovered | not applicable | ||||||||||||||||||||||||||||||||||||
61 | #0058 | Y | AU-025-1714 | 05/02/22 | AUS | Melbourne | Seeking_Health_care | 18/01/22 | Y | PCR | Y | AstraZeneca | 2 | Y | 12/01/22 | Y | Y | N | N | Y | Y | N | not applicable | not applicable | F | RR | 1 | 22/01/20 | Y | Ocrevus | 12/10/21 | 0.99 | 20/08/21 | N | N | Current Smoker | 68 | 160 | 26.5625 | N | N | N | N | N | No | 12/01/22 | N | Unknown | not applicable | |||||||||||||||||||||||||||
62 | #0059 | Y | AU-009-0271 | 05/02/22 | AUS | Melbourne | Seeking_Health_care | 09/11/21 | Y | PCR | Y | Pfizer | 2 | Y | 08/11/21 | Y | Y | Y | Y | N | N | N | diarrhoea | not applicable | not applicable | F | RR | 0 | 31/03/21 | Y | Ocrevus | 01/06/21 | 2.31 | 01/06/21 | N | Y | #DIV/0! | N | N | N | N | N | No | Obesity | 08/11/21 | N | Recovered | 18/12/21 | not applicable | |||||||||||||||||||||||||||
63 | #0060 | Y | AU-025-0334 | 15/02/22 | AUS | Melbourne | Unknown | 31/01/22 | Y | Serology | Y | Pfizer | 2 | N | N | N | N | N | N | N | N | not applicable | not applicable | F | RR | 1.5 | 28/04/21 | Y | Ocrevus | 28/01/21 | 0.88 | 28/01/21 | N | Y | #DIV/0! | N | N | N | N | N | No | Asthma | N | not applicable | ||||||||||||||||||||||||||||||||
64 | #0061 | Y | AU-025-0243 | 15/02/22 | AUS | Melbourne | Seeking_Health_care | 17/01/22 | Y | PCR | Y | Pfizer | 3 | Y | 17/01/22 | N | N | N | Y | N | N | N | rhinorrhea | not applicable | not applicable | F | RR | 1.5 | 24/11/21 | N | Ocrevus | 09/06/21 | 2.24 | 23/07/21 | Y | First Trimester | N | Never smoked | #DIV/0! | N | N | N | N | N | No | 17/01/21 | N | Recovered | 31/01/22 | not applicable | ||||||||||||||||||||||||||
65 | #0062 | Y | AU-025-1965 | 15/02/22 | AUS | Melbourne | Seeking_Health_care | 10/01/22 | Y | PCR | Y | Pfizer | 3 | Y | 09/01/22 | Y | Y | Y | Y | N | Y | N | F | SP | 6 | 22/06/21 | Y | Siponimod | 10/01/22 | 0.18 | 08/06/21 | N | N | 71 | 168 | 25.15589569 | N | N | N | N | N | No | 09/01/22 | N | Unknown | continued | Sotrovimab | |||||||||||||||||||||||||||||
66 | #0063 | Y | AU-025-0274 | 15/02/22 | AUS | Melbourne | Seeking_Health_care | 10/01/22 | Y | PCR | Y | Pfizer | 2 | Y | 02/01/22 | Y | Y | Y | N | N | N | N | F | RR | 0 | 12/06/19 | Y | Tysabri | 30/11/21 | 3.5 | 07/09/21 | Y | Second trimester | N | #DIV/0! | N | N | N | N | N | No | 02/01/22 | N | Recovered | 10/01/22 | not applicable | ||||||||||||||||||||||||||||||
67 | #0064 | Y | AU-025-0044 | 21/02/22 | AUS | Melbourne | Seeking_Health_care | 11/01/22 | Y | PCR | Y | AstraZeneca | 2 | Y | 07/01/22 | Y | Y | Y | Y | Y | Y | N | diarrhoea | not applicable | not applicable | F | RR | 2 | 17/03/21 | Y | gilenya | 06/01/22 | N | Y | 60 | 166 | 21.77384236 | N | N | N | N | N | In remission | N | Unknown | |||||||||||||||||||||||||||||||
68 | #0065 | Y | AU-025-0575 | 21/02/22 | AUS | Melbourne | Seeking_Health_care | 26/01/22 | Y | PCR | Y | Pfizer | 2 | Y | 26/01/22 | Y | Y | Y | Y | unknown | unknown | unknown | not applicable | not applicable | F | RR | 1.5 | 12/04/21 | y | natalizumab | 03/01/22 | 3.31 | 13/09/21 | N | N | #DIV/0! | N | N | N | N | N | No | 25/01/22 | N | Unknown | discontinued or dose delayed whilst unwell | ||||||||||||||||||||||||||||||
69 | #0066 | N | AU-025-2205 | 21/02/22 | AUS | melbourne | Seeking_Health_care | 14/01/22 | Y | PCR | N | Pfizer | 0 | Y | 14/01/22 | Y | Y | Y | Y | Y | N | N | diarrhoea | not applicable | not applicable | M | RR | 1 | 21/09/21 | Y | ocrelizumab | 23/08/21 | 3.43 | 23/08/21 | N | N | #DIV/0! | N | N | N | N | N | No | 14/01/22 | N | Unknown | ||||||||||||||||||||||||||||||
70 | #0067 | N | AU-009-1818 | 21/02/22 | AUS | melbourne | Seeking_Health_care | 01/10/21 | Y | PCR | N | Pfizer | 3 | Y | 01/10/21 | Y | Y | unknown | unknown | unknown | unknown | unknown | not applicable | not applicable | F | RR | 2 | 30/06/2017 | N | 1.46 | 18/08/21 | N | N | #DIV/0! | N | N | N | N | N | No | 01/10/21 | N | Unknown | |||||||||||||||||||||||||||||||||
71 | #0068 | Y | AU-025-0014 | 22/02/22 | AUS | Melbourne | Seeking_Health_care | 08/10/21 | Y | PCR | N | 0 | Y | 01/10/21 | N | Y | Y | N | N | Y | N | diarrhoea | not applicable | not applicable | M | RR | 6.5 | 24/3/21 | Y | Ocrevus | 19/4/21 | N | N | Ex-smoker | 74 | 175 | 24.16326531 | N | N | N | N | N | No | 1/10/21 | N | Unknown | ||||||||||||||||||||||||||||||
72 | #0069 | Y | AU-025-0418 | 22/02/22 | AUS | Melbourne AH | Seeking_Health_care | 07/01/22 | Y | PCR | Y | Pfizer | 2 | Y | 07/01/2022 | Y | Y | N | Y | N | N | N | unknown | not applicable | not applicable | F | RR | 3 | 10/10/2021 | Y | Ocrevus | 11/11/2021 | N | N | 72 | 168 | 25.51020408 | N | N | N | N | N | No | N | Recovered | 22/02/22 | continued | |||||||||||||||||||||||||||||
73 | #0070 | Y | AU-016-0020 | 23/02/22 | AUS | Sydney | Seeking_Health_care | 26/08/2021 | Y | PCR | Y | AstraZeneca | 1 | Y | 28/08/21 | N | Y | Y | N | N | N | N | not applicable | not applicable | M | RR | 8 | 03/10/2019 | Cladribine | 13/11/2018 | 1.3 | 15/04/21 | N | N | #DIV/0! | N | N | N | N | N | No | 28/08/21 | Y | 19/08/21 | 15/09/21 | N | Recovered | 09/09/21 | continued | Sotrovimab & dexamethsone | Was in Hospital for UTI, because close contact during initial stay in ward | |||||||||||||||||||||||||
74 | #0071 | Y | AU-025-0488 | 24/02/22 | AUS | Melbourne- AH | Seeking_Health_care | 08/12/22 | Y | PCR | N | Y | 06/12/21 | Y | Y | Y | Y | N | N | N | N | not applicable | not applicable | F | RR | 2 | 18/02/20 | Y | Ocrevus | 17/5/21 | 0.7 | NA | N | N | Never smoked | #DIV/0! | N | N | N | N | N | No | 06/12/21 | N | Recovered | ? | continued | none | ||||||||||||||||||||||||||||
75 | #0072 | Y | AU-025-2245 | 24/02/22 | AUS | Melbourne- AH | Seeking_Health_care | 07/01/22 | Y | PCR | Y | Pfizer | 3 | Y | 07/01/22 | N | Y | N | N | N | N | N | N | not applicable | not applicable | F | RR | 2.5 | 26/05/21 | Y | Tysabri | 03/12/2021 | 1.98 | NA | N | ? | 57 | #DIV/0! | N | N | N | N | N | No | 07/01/22 | N | Recovered | ? | discontinued or dose delayed whilst unwell | none | ||||||||||||||||||||||||||
76 | #0073 | Y | AU-025-2272 | 24/02/22 | AUS | Melbourne- AH | Seeking_Health_care | 07/01/22 | Y | PCR | Y | Pfizer and AZ | 4 | Y | 07/01/22 | Y | Y | Y | Y | N | Y | N | N | not applicable | not applicable | M | RR | 2 | 15/12/2021 | N | 07/06/2021 | 2.58 | NA | N | ? | #DIV/0! | N | N | N | N | N | No | 07/01/22 | N | Recovered | ? | not applicable | none | ||||||||||||||||||||||||||||
77 | #0074 | Y | AU-025-1581 | 24/02/22 | AUS | Melbourne- AH | Seeking_Health_care | 18/01/22 | Y | PCR | Y | AstraZeneca | 1 | Y | 05/01/22 | Y | Y | N | Y | Y | N | N | N | not applicable | not applicable | M | RR | 3 | 16/11/2021 | Y | Gilenya | 04/01/22 | 1.28 | NA | N | N | ? | #DIV/0! | N | N | N | N | N | No | 05/01/21 | N | Unknown | ? | continued | none | ||||||||||||||||||||||||||
78 | #0075 | Y | AU-009-0418 | 24/02/22 | AUS | Melbourne- AH | Seeking_Health_care | 02/02/22 | Y | PCR | Y | Pfizer | 3 | Y | 01/02/2022 | Y | Y | Y | Y | N | N | N | N | not applicable | not applicable | F | RR | 4 | 20/02/21 | Y | Ocrevus | 21/09/2020 | NA | NA | N | N | Ex-smoker | 70 | #DIV/0! | N | N | N | N | N | No | 01/02/2022 | N | Recovered | unknown | none | ||||||||||||||||||||||||||
79 | #0076 | Y | AU-025-0245 | 24/02/22 | AUS | Melbourne- AH | Seeking_Health_care | 04/01/2022 | Y | PCR | Y | Y | 01/02/2022 | N | Y | Y | Y | Y | Y | N | N | not applicable | not applicable | F | RR | 2 | 24/02/2021 | Y | Tysabri | 14/02/2022 | 3.46 | 13/02/2022 | N | N | ? | 68 | 160 | 26.5625 | N | N | N | N | N | No | 02/01/2022 | N | Other | discontinued or dose delayed whilst unwell | none | |||||||||||||||||||||||||||
80 | #0077 | Y | AU-009-0843 | 25/02/22 | AUS | Melbourne- AH | Seeking_Health_care | 01/01/22 | Y | PCR | Y | Pfizer | 2 | N | N | N | N | N | N | N | N | N | N | not applicable | not applicable | F | RR | 1.5 | 14/12/21 | N | 20/12/21 | 0.37 | 22/11/21 | N | Y | Current Smoker | 70.1 | #DIV/0! | N | N | N | N | N | In remission | 01/01/22 | N | Unknown | not applicable | sotrovimab | |||||||||||||||||||||||||||
81 | #0078 | Y | AU-025-1656 (pt contracted twice) | 25/2/22 | AUS | Melbourne- AH | Seeking_Health_care | 25/11/21 | Y | PCR | Y | Pfizer | 2 | Y | 24/11/21 | Y | Y | N | N | Y | Y | N | N | not applicable | not applicable | F | RR | 0 | 14/07/21 | Y | Gilenya | 23/11/21 | 0.5 | 28/6/21 | N | N | ? | #DIV/0! | N | N | N | N | N | No | 24/11/21 | N | Recovered | 7/12/21 | continued | none | ||||||||||||||||||||||||||
82 | #0079 | Y | AU-025-1656 (pt contracted twice) | 25/2/22 | AUS | Melbourne- AH | Seeking_Health_care | 10/01/22 | Y | PCR | Y | Pfizer | 2 | Y | 09/01/22 | Y | Y | Y | N | N | N | N | N | not applicable | not applicable | F | RR | 0 | 14/07/21 | Y | Gilenya | 08/01/22 | 0.5 | 28/6/21 | N | N | ? | #DIV/0! | N | N | N | N | N | No | 09/01/22 | N | Unknown | continued | sotrovimab | |||||||||||||||||||||||||||
83 | #0080 | Y | AU-025-0355 | 01/03/22 | AUS | Melbourne- AH | Seeking_Health_care | 04/01/2022 | Y | PCR | N | AstraZeneca | 1 | Y | 04/01/2022 | Y | Y | N | N | N | N | N | N | not applicable | not applicable | F | RR | 2 | 29/06/21 | Y | Tysabri | 08/12/2021 | 2.98 | 15/09/2021 | N | N | Not Current smoker | 52 | #DIV/0! | N | N | N | N | N | No | 04/01/2022 | N | Unknown | continued | appears to have had vaccine after infected but no other treatment | has since passed away (02/06/2021) due to malignancy | |||||||||||||||||||||||||
84 | #0081 | Y | AU-025-1747 | 01/03/22 | AUS | Melbourne- AH | Seeking_Health_care | 25/08/2020 | Y | PCR | N | Pfizer | 1 | Y | 23/08/2020 | Y | Y | Y | Y | N | N | Y | N | not applicable | not applicable | F | RR | 9 | 20/17/2017 | Y | Tecfidera | 22/08/2020 | NA | NA | N | Y | Not Current smoker | #DIV/0! | N | N | N | N | N | Current | Underlying agressive melanoma | 23/08/2020 | N | Recovered | 10/10/2020 | continued | none | |||||||||||||||||||||||||
85 | #0082 | Y | AU-025-0082 (pt contracted twice) | 01/03/22 | AUS | Melbourne- AH | Seeking_Health_care | 24/11/2021 | Y | PCR | Y | other | 3 | Y | 24/11/2021 | Y | Y | N | N | N | N | N | N | not applicable | not applicable | M | RR | 6 | 07/07/2021 | Y | Ocrevus | 06/10/2021 | 0.89 | 06/10/2021 | N | N | Not Current smoker | #DIV/0! | N | N | N | N | N | No | 24/11/2021 | N | Recovered | continued | sotrovimab | |||||||||||||||||||||||||||
86 | #0083 | Y | AU-025-0082 (pt contracted twice) | 01/03/22 | AUS | Melbourne- AH | Seeking_Health_care | 10/01/2022 | Y | PCR | Y | other | 3 | Y | 10/01/2022 | Y | Y | Y | Y | N | Y | N | N | not applicable | not applicable | M | RR | 6 | 07/07/2021 | Y | Ocrevus | 06/10/2021 | 0.89 | 06/10/2021 | N | N | Not Current smoker | #DIV/0! | N | N | N | N | N | No | 10/01/2022 | N | Unknown | continued | sotrovimab | |||||||||||||||||||||||||||
87 | #0084 | Y | AU-025-2326 | 01/03/22 | AUS | Melbourne- AH | Seeking_Health_care | 31/12/2021 | Y | PCR | Y | Pfizer | 1 | N | NA | N | N | N | N | N | N | N | N | not applicable | not applicable | M | RR | 1 | 14/12/2021 | Y | Ocrevus | 17/12/2021 | 1.53 | 16/11/2021 | N | N | unknown | 87 | #DIV/0! | N | N | N | N | N | No | NA | N | Unknown | discontinued or dose delayed whilst unwell | none | ||||||||||||||||||||||||||
88 | #0085 | Y | AU-009-1225 | 01/03/22 | AUS | Melbourne- AH | Seeking_Health_care | 01/12/2021 | Y | PCR | Y | Pfizer | 1 | Y | 30/11/2021 | N | N | N | Y | N | Y | N | N | not applicable | not applicable | F | RR | 1.5 | 23/09/2021 | Y | Ocrevus | 03/09/2021 | 1.97 | 23/09/2021 | N | N | Not Current smoker | #DIV/0! | N | N | N | N | N | No | CIN (recovered 2013) | 30/11/2012 | N | Recovered | continued | none | ||||||||||||||||||||||||||
89 | #0086 | Y | AU-025-1960 | 01/03/22 | AUS | Melbourne- AH | Seeking_Health_care | 11/01/2022 | Y | PCR | Y | Pfizer | 3 | Y | 10/1/2022 | Y | Y | Y | N | Y | N | N | N | not applicable | not applicable | F | RR | 4 | 04/01/2022 | Y | steroids | prednisolone | 0.9 | 22/12/2021 | N | Y | Not Current smoker | #DIV/0! | Y | Y | N | N | N | No | 10/01/2022 | N | Recovered | continued | sotroviamab | Recovered | ||||||||||||||||||||||||||
90 | #0087 | Y | AU-009-0614 | 02/03/22 | AUS | Melbourne- AH | Seeking_Health_care | 31/05/2020 | Y | PCR | N | Pfizer | 3 | Y | 27/05/2020 | N | Y | Y | Y | N | N | N | N | not applicable | not applicable | F | RR | 2 | 18/12/2019 | Y | Ocrevus | 14/04/2020 | 0.8 | 23/03/20 | N | N | Not Current smoker | #DIV/0! | N | N | N | N | N | No | 27/05/2020 | N | Recovered | 05/06/2020 | continued | none | ||||||||||||||||||||||||||
91 | #0088 | Y | AU-025-1833 | 02/03/22 | AUS | Melbourne- AH | Seeking_Health_care | 06/01/2022 | Y | PCR | Y | Pfizer | 2 | Y | 04/01/2022 | Y | Y | Y | Y | N | Y | N | N | not applicable | not applicable | F | RR | 0 | 23/06/2021 | Y | Ocrevus | 07/09/2021 | 2.68 | 24/08/2021 | N | N | unkown | #DIV/0! | N | N | N | N | N | No | 04/01/2022 | N | Unknown | continued | none | |||||||||||||||||||||||||||
92 | #0089 | Y | AU-025-2294- not much on profile check for doub | 02/03/22 | AUS | Melbourne- AH | Seeking_Health_care | 07/02/2022 | Y | PCR | N | 0 | Y | 07/02/2022 | Y | Y | N | N | N | N | N | N | not applicable | not applicable | M | RR | 2 | 01/03/2022 | Never treated | 0.88 | #DIV/0! | |||||||||||||||||||||||||||||||||||||||||||||
93 | #0090 | Y | AU-025-0036 | 02/03/22 | AUS | Melbourne- AH | Seeking_Health_care | 01/09/2020 | Y | PCR | N | Pfizer | 2 | Y | 01/09/2020 | Y | Y | Y | Y | N | Y | N | N | not applicable | not applicable | F | RR | 6.5 | 17/07/2019 | Y | Ocrevus | 28/10/2020 | 1.2 | 28/05/2020 | N | Y | unkown | 72 | 150 | 32 | Y | N | N | N | N | No | 01/09/2020 | N | Recovered | 05/09/2020 | continued | none | ||||||||||||||||||||||||
94 | #0091 | Y | AU-009-0970 | 02/03/22 | AUS | Melbourne- AH | Seeking_Health_care | 02/12/2021 | Y | PCR | N | 0 | Y | 02/12/2021 | Y | Y | Y | Y | N | Y | N | N | not applicable | not applicable | F | RR | 0 | 09/11/2021 | Y | Tysabri | 22/11/2021 | 2.77 | 27/09/2021 | N | N | Not Current smoker | 72 | 173 | 24.05693475 | N | N | N | N | N | No | 02/12/2021 | N | Recovered | 13/12/2021 | continued | none | |||||||||||||||||||||||||
95 | #0092 | Y | AU-025-1864 | 02/03/22 | AUS | Melbourne- AH | Seeking_Health_care | 22/11/2021 | Y | PCR | Y | Moderna | 1 | Y | 22/11/2021 | Y | N | N | N | N | N | N | N | not applicable | not applicable | M | RR | 4.5 | 31/03/2021 | Y | Ocrevus | 06/09/2021 | 1.29 | 21/01/2021 | N | N | Not Current smoker | #DIV/0! | N | N | N | N | N | No | 22/11/2021 | N | Unknown | continued | none | |||||||||||||||||||||||||||
96 | #0093 | Y | AU-009-0271 | 02/03/22 | AUS | Melbourne- AH | Seeking_Health_care | 09/11/2021 | Y | PCR | Y | Pfizer | 2 | Y | 09/11/2021 | Y | Y | Y | Y | N | N | N | Y | not applicable | not applicable | F | RR | 0 | 31/03/2021 | Y | Ocrevus | 01/06/2021 | 2.31 | 01/06/2021 | Y | First Trimester | Y | unkown | #DIV/0! | N | N | N | N | N | No | obesity | 08/11/2021 | N | Unknown | continued | none | |||||||||||||||||||||||||
97 | #0094 | Y | AU-025-0509 | 02/03/22 | AUS | Melbourne- AH | Seeking_Health_care | 25/01/2022 | Y | PCR | N | 0 | Y | 25/01/2022 | Y | Y | Y | Y | N | Y | N | Y | not applicable | not applicable | F | RR | 4.5 | 18/05/2021 | Y | stem cell transplplant | 01/02/2019 | 2.08 | 10/03/2021 | N | N | Not Current smoker | #DIV/0! | N | N | N | N | N | No | 25/01/2022 | N | Unknown | not applicable | none | ||||||||||||||||||||||||||||
98 | #0095 | Y | AU-009-0175 | 02/03/22 | AUS | Melbourne- AH | Seeking_Health_care | 27/12/2021 | Y | PCR | Y | AstraZeneca | 2 | Y | 27/12/2021 | Y | Y | Y | Y | N | N | Y | Y | not applicable | not applicable | F | RR | 1.5 | 29/02/2020 | Y | Ocrevus | 27/09/2021 | 1.75 | 27/09/2021 | N | Y | Not Current smoker | #DIV/0! | Y | N | N | N | N | No | obesity | 27/12/2021 | N | Recovered | 19/01/2022 | not applicable | none | |||||||||||||||||||||||||
99 | #0096 | Y | AU-025-0234 | 02/03/22 | AUS | Melbourne- AH | Seeking_Health_care | 02/01/2022 | Y | PCR | N | N | NA | N | N | N | N | N | N | N | N | not applicable | not applicable | M | RR | 0 | 26/05/2021 | Y | Tysabri | 10/12/2021 | 3.7 | 17/09/2021 | N | N | Not Current smoker | 92 | 187 | 26.30901656 | N | N | N | N | N | No | NA | N | Unknown | discontinued or dose delayed whilst unwell | none | |||||||||||||||||||||||||||
100 | #0097 | Y | AU-025-1949 | 02/03/22 | AUS | Melbourne- AH | Seeking_Health_care | 07/01/2022 | Y | PCR | N | Y | 06/01/2022 | Y | Y | Y | Y | Y | Y | N | Y | not applicable | not applicable | F | RR | 3 | 01/09/2021 | Y | Ocrevus | 13/12/2021 | 1.26 | 13/12/2021 | N | N | Not Current smoker | 75 | 169 | 26.25958475 | N | N | N | N | N | No | 06/01/2022 | N | Recovered | 07/02/2022 | continued | sotrovimab | Recovered |